A Report By Leading Clinical Researchers On The Current Quantitative Imaging Tools For Lung Cancer Drug Assessment

Main Category: Lung Cancer
Also Included In: Medical Devices;  MRI / PET / Ultrasound;  Cancer / Oncology
Article Date: 04 Jul 2008 - 2:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

Research and Markets has announced the addition of the "Quantitative Imaging Tools for Lung Cancer Drug Assessment" report to their offering.

This monograph presents chapters written by leading clinical researchers in the field of lung cancer, where high resolution 3-D imaging technology appears to hold the greatest near-term promise, as well as contributions from recognized experts in CAD, medical information technology systems, regulatory procedure, x-ray standards development, and clinical trial design. These authors discuss the current state-of-the-art and provide a road map for directing further research in lung cancer as well as other organ systems.

Presents chapters written by leading clinical researchers in the field of lung cancer, where high resolution 3-D imaging technology appears to hold the greatest near-term promise, as well as contributions from recognized experts in CAD, medical information technology systems, regulatory procedure, x-ray standards development, and clinical trial design. These expert contributors discuss the current state of the art and provide a road map for directing further research in lung cancer as well as other organ systems.

Key Topics Covered:

- Incorporating Imaging into Drug Development: An Industry Perspective (Philip S. Murphy and Debasish Roychowdhury).

- Developing Imaging Tools for Drug Development: Critical Technology, Clinical Data and Regulatory (Rafal Dziadziuszko, Fred R. Hirsch and Paul A. Bunn, Jr).

- Quantitative Imaging in CT Lung Cancer Drug Development and Evaluation (Ricardo S. Avila).

- Volumetric CT Imaging for Response Assessment in Lung Cancer: A Platform for Translational Research (Binsheng Zhao and Lawrence H. Scwhartz).

- Emerging Radiological Software Standards and Development Technologies: Impact on Clinical Translation and Trials (John Pearson, Lawrence Tarbox, Gianluca Paladini, John G. Wolodzko, Paula M. Jacobs, and Zhenghong Lee).

- Statistical Considerations Underlying Therapeutic Response Criteria for Lung Cancer: A Review in the Context of Emergence of Multi-Slice CT Scanner and Computer Assisted Diagnostic Algorithm for Volumetric Assessment (Madhu Mazumdar and Xi Kathy Zhou).

- Programs Supporting Quantitative Imaging in Biomedicine at the National Institute for Standards and Technology (Thomas M. Baer and Charles W. Clark).

For more information visit here.

Research and Markets